Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at IMMUNOLOGY2024™|May 3-7, 2024|Booth #512
1 2 3

Efna1

ephrin-A1

EFNA1; ephrin-A1; EPLG1, TNFAIP4; ECKLG; LERK1; TNF alpha-induced protein 4; ligand of eph-related kinase 1; immediate early response protein B61; eph-related receptor tyrosine kinase ligand 1; tumor necrosis factor alpha-induced protein 4; tumor necrosis; B61; EFL1; EPLG1; LERK-1; TNFAIP4;

Efna2

ephrin-A2

EFNA2; ephrin-A2; EPLG6; ELF 1; LERK6; EFNA 2; EFNA2_HUMAN; ELF1; Eph related receptor tyrosine kinase ligand 6; EPH-related receptor tyrosine kinase ligand 6; EphrinA2; HEK7 L; HEK7 ligand; HEK7-L; HEK7L; LERK-6; Ligand of eph related kinase 6; ELF-1;

EFNA3

ephrin-A3

EFNA3; ephrin-A3; EPLG3; Ehk1 L; LERK3; EFL-2; LERK-3; EHK1 ligand; ligand of eph-related kinase 3; eph-related receptor tyrosine kinase ligand 3; EFL2; Ehk1-L;

EFNA4

ephrin-A4

EFNA4; ephrin-A4; EPLG4; LERK4; LERK-4; ligand of eph-related kinase 4; eph-related receptor tyrosine kinase ligand 4; EFL4; FLJ57652; MGC125826;

EFNA5

ephrin-A5

EFNA5; ephrin-A5; EPLG7; AF1; LERK7; AL-1; LERK-7; eph-related receptor tyrosine kinase ligand 7; EFL5; RAGS; GLC1M;

EFNB1

ephrin-B1

EFNB1; ephrin-B1; CFNS, craniofrontonasal syndrome (craniofrontonasal dysplasia) , EPLG2; Elk L; LERK2; CFND; CFNS; Craniofrontonasal syndrome (craniofrontonasal dysplasia); EFL 3; EFL-3; EFL3; EFNB1_HUMAN; ELK ligand; ELK-L; Eph related receptor tyrosine kinase ligand 2; EPH-related receptor tyrosine kinase ligand 2; EPLG2; LERK 2; LERK-2; Ligand of eph related kinase 2; MGC8782; OTTHUMP00000023456; ligand of eph-related kinase 2;

Efnb2

Ephrin-B2

EPHB2; EPH receptor B2; DRT; EK5; ERK; CAPB; Hek5; PCBC; EPHT3; Tyro5; MGC87492; ephrin type-B receptor 2; EPH-like kinase 5; eph tyrosine kinase 3; elk-related tyrosine kinase; protein-tyrosine kinase HEK5; tyrosine-protein kinase TYRO5; renal carcinoma antigen NY-REN-47; tyrosine-protein kinase receptor EPH-3; developmentally-regulated Eph-related tyrosine kinase; EphB2; EC=2.7.10.1; Developmentally-regulated Eph-related tyrosine kinase; CAPB; PCBC; EFN B2; EFNB 2; EFNB2; Eph related receptor tyrosine kinase ligand 5; EPH-related receptor tyrosine kinase ligand 5; Ephrin-B2; EphrinB2; EPLG 5; EPLG5; Htk L; HTK ligand; HTK-L; HTKL; LERK 5; LERK-5; LERK5; Ligand of eph related kinase 5 antibody; MGC126226; MGC126227; MGC126228; OTTMUSP00000024973; Htk-L; ELF-2; NLERK-1;

EFNB3

ephrin-B3

EFNB3; ephrin-B3; EPLG8; LERK 8; Ephrin B3; eph-related receptor tyrosine kinase ligand 8; EPH-related receptor transmembrane ligand ELK-L3; EFL6; LERK8;

NPHS1

nephrosis 1, congenital, Finnish type (nephrin)

NPHS1; nephrosis 1, congenital, Finnish type (nephrin); CNF; NPHN; nephrin; nephrin; renal glomerulus-specific cell adhesion receptor;

OPHN1

oligophrenin 1

OPHN1; oligophrenin 1; mental retardation, X linked 60 , MRX60; oligophrenin-1; ARHGAP41; OPN1; OTTHUMP00000023451; mental retardation, X-linked 60; oligophrenin-1, Rho-GTPase activating protein; MRX60;

NPHP4

nephronophthisis 4

NPHP4; nephronophthisis 4; nephrocystin-4; KIAA0673; nephrocystin 4; nephroretinin; POC10; POC10 centriolar protein homolog (Chlamydomonas); SLSN4; NPHP4_HUMAN; POC10 centriolar protein homolog;

DISC1

disrupted in schizophrenia 1

DISC1; disrupted in schizophrenia 1; disrupted in schizophrenia 1 protein; SCZD9; C1orf136; FLJ13381; FLJ21640; FLJ25311; FLJ41105; KIAA0457;

NPNT

nephronectin

NPNT; nephronectin; preosteoblast EGF-like repeat protein with MAM domain; Nctn; POEM; AA682063; AI314031; 1110009H02Rik;

NPHP1

nephronophthisis 1 (juvenile) homolog (human)

NPHP1; nephronophthisis 1 (juvenile) homolog (human); nephrocystin-1; JBTS4; Juvenile nephronophthisis 1 protein; Nephrocystin 1; NPH1; SLSN1;

TINAG

tubulointerstitial nephritis antigen

TINAG; tubulointerstitial nephritis antigen; TIN AG; TIN-Ag; TIN1; TIN2; TINAG_HUMAN;

TINAGL1

tubulointerstitial nephritis antigen-like 1

TINAGL1; tubulointerstitial nephritis antigen-like 1; LCN7, lipocalin 7 , TINAG like 1; tubulointerstitial nephritis antigen-like; ARG1; LIECG3; P3ECSL; TINAGRP; Androgen regulated gene 1; GIS5; Glucocorticoid inducible protein 5; Glucocorticoid inducible protein; LCN7; Lipocalin 7; Lipocalin7; OLRG 2; OLRG2; Oxidized LDL responsive gene 2; Oxidized LDL responsive gene 2 protein; TIN Ag related protein; TIN Ag RP; TINAG like 1; TINAGL 1; TINAGL; Tubulointerstitial nephritis antigen like 1; Tubulointerstitial nephritis antigen like; Tubulointerstitial nephritis antigen related protein; OLRG-2; TIN-Ag-RP; TINAG-like 1; TIN Ag-related protein; androgen-regulated gene 1; oxidized-LDL responsive gene 2; glucocorticoid-inducible protein 5; tubulointerstitial nephritis antigen-related protein;

Nepn

nephrocan

RGD1307755;

Nphp3

nephronophthisis 3 (adolescent)

Nephrin

nephrosis 1, congenital, Finnish type (nephrin)

logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends